Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

Affiliations

• ¹ Department of Urology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland kari.tikkinen@gmail.com.
• ² Department of Public Health, University of Helsinki, 00014 Helsinki, Finland.
• ³ Urology Section, Minneapolis VAMC and Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA.
• ⁴ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
• ⁵ Department of Medicine, Innlandet Hospital Trust-division, Gjøvik, Norway.
• ⁶ Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
• ⁷ Cochrane Consumers, London, UK.
• ⁸ Citizens United for Evidence-Based Medicine, Virginia, USA.
• ⁹ Cameroon Consumer Service Organization (CamCoSO), Bamenda, Cameroon.
• ¹⁰ Coalition of Civil Society Organizations Cameroon, Bamenda, Cameroon.
• ¹¹ Department of General Practice and Elderly Medicine, University Medical Centre-Groningen, University of Groningen, Groningen, The Netherlands.
• ¹² Institute of Primary Care, Geneva University Hospitals, Geneva, Switzerland.
• ¹³ Unit of Primary Care Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• ¹⁴ Division General Internal Medicine, University Hospitals of Geneva, Geneva, Switzerland.
• ¹⁵ School of Medicine, University of Miyazaki, Miyazaki, Japan.
• ¹⁶ Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
• ¹⁷ Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.
• ¹⁸ The BMJ, London, UK.
• ¹⁹ Division of Clinical Epidemiology, University Hospitals of Geneva, Geneva, Switzerland.